Latest filing published 10 Oct 2026 for Eastwood Bio-Medical Canada Inc., €116. Read the official filing
Yunji Kim discloses dealings in Eastwood Bio-Medical Canada Inc. to SEDI. Between 28 May 2026 and 8 October 2026, the trades on record add up to 50 filings.
The open-market side counts 29 purchases for €11k alongside 21 sales for €23k. Sales outweigh purchases by €12k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €306. Scaled by market value, the purchases weigh a median 0.0004% of market cap (sample: 25 purchases). No cluster: in 29 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 10 October 2026: an open-market sale of €116, in Eastwood Bio-Medical Canada Inc. The clock since the last published purchase (5 October 2026) now reads 12 days. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 50 declarations